Samsung Medical Center
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Adequate Definition of Delayed Graft Function in Living and Deceased Donor Kidney Transplantation
Completed
- Conditions
- Living Donor Kidney TransplantationDeceased Donor Kidney Transplantation
- Interventions
- Procedure: kidney transplantation, living or deceased donor
- First Posted Date
- 2014-03-06
- Last Posted Date
- 2017-04-25
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 800
- Registration Number
- NCT02080117
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Comparison Between P2Y12 Antagonist Monotherapy and Dual Antiplatelet Therapy After DES
Not Applicable
- Conditions
- Coronary Artery Disease
- Interventions
- Drug: P2Y12 antagonist monotherapy
- First Posted Date
- 2014-03-05
- Last Posted Date
- 2019-01-31
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 3000
- Registration Number
- NCT02079194
- Locations
- π°π·
Cardiac and Vascular Center; Samsung Medical Center, Seoul, Korea, Republic of
Moyamoya Disease Biomarkers in Patients With Intracranial Atherosclerotic Stroke
- Conditions
- Intracranial Steno-occlusive DiseaseMoyamoya DiseaseIntracranial Atherosclerotic Stroke
- First Posted Date
- 2014-02-28
- Last Posted Date
- 2017-04-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 400
- Registration Number
- NCT02074111
- Locations
- π°π·
Department of Neurology, Samsung Medical Center, Seoul, Korea, Republic of
Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy
Phase 4
Completed
- Conditions
- Polypoidal Choroidal Vasculopathy Without Active Polyp
- Interventions
- First Posted Date
- 2014-02-26
- Last Posted Date
- 2018-09-05
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 46
- Registration Number
- NCT02072408
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
π°π·Seoul National University Bundang Hospital, Seongnam, Gyunggi-do, Korea, Republic of
π°π·Konyang University Kim's Eye Hospital, Seoul, Korea, Republic of
Circulating Free DNA Analysis in Gastrointestinal Cancer, Genitourinary Cancer, Rare Cancer
Completed
- Conditions
- Gastric Cancer
- First Posted Date
- 2014-02-20
- Last Posted Date
- 2019-05-20
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 396
- Registration Number
- NCT02067754
- Locations
- π°π·
Samsung Medical center, Seoul, Korea, Republic of
Prognostic Relevance of Biological Subtype in Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2014-02-17
- Last Posted Date
- 2017-05-01
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 202
- Registration Number
- NCT02063906
- Locations
- π°π·
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of
Xeloda Maintenance Versus BSC in Metastatic Colorectal Cancer
- First Posted Date
- 2014-02-12
- Last Posted Date
- 2017-04-27
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT02060669
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Epstein-Barr Virus Status in Diffuse Large B Cell Lymphoma
Completed
- Conditions
- Diffuse Large B-cell Lymphoma
- Interventions
- Other: EBER
- First Posted Date
- 2014-02-12
- Last Posted Date
- 2014-02-12
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 571
- Registration Number
- NCT02060435
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Prognostic Molecular Markers in Patients With Myelodysplastic Syndrome
Completed
- Conditions
- Myelodysplastic Syndrome
- Interventions
- Genetic: spliceosome
- First Posted Date
- 2014-02-12
- Last Posted Date
- 2014-02-12
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 58
- Registration Number
- NCT02060409
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Platelet Response During the Second Cycle of Decitabine Can Predict Response and Survival for Myelodysplastic Syndrome
- Conditions
- Myelodysplastic Syndrome
- First Posted Date
- 2014-01-27
- Last Posted Date
- 2014-01-27
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 1
- Registration Number
- NCT02045654
- Locations
- π°π·
Division of Hematology Oncology, Samsung Medical Center, Seoul, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath